What is the price target for NRO stock?
5 analysts have analysed NRO.PA and the average price target is 53.04 EUR. This implies a price increase of 53.74% is expected in the next year compared to the current price of 34.5.
NEURONES (NRO.PA) Forecast, Price Target & Analyst Ratings
EPA:NRO • FR0004050250
Current stock price
34.5 EUR
+0.5 (+1.47%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEURONES (NRO.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€53.04
Upside
+ 53.74%
From current price of €34.50 to mean target of €53.04, Based on 5 analyst forecasts
Low
€52.52
Median
€53.04
High
€54.60
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for NRO.PA. The average price target is 53.04 EUR. This implies a price increase of 53.74% is expected in the next year compared to the current price of 34.5.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
NRO.PA was analyzed by 5 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NRO.PA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NRO.PA. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 665.379M 14.74% | 741.175M 11.39% | 810.353M 9.33% | 865.57M 6.81% | 913.04M 5.48% | 968.59M 6.08% | 1.005B 3.76% | |
| EBITDA YoY % growth | 88.796M 16.34% | 91.449M 2.99% | 95.484M 4.41% | 93.93M -1.63% | 99.99M 6.45% | 115.14M 15.15% | 119.38M 3.68% | |
| EBIT YoY % growth | 72.222M 17.16% | 74.692M 3.42% | 77.829M 4.20% | 75.75M -2.67% | 81.81M 8.00% | 96.96M 18.52% | 100.52M 3.67% | |
| Operating Margin | 10.85% | 10.08% | 9.60% | 8.75% | 8.96% | 10.01% | 10.00% | |
| EPS YoY % growth | N/A 23.34% | N/A 12.53% | N/A -4.55% | 2.22 4.76% | 2.42 9.09% | 2.73 12.50% | 2.89 5.99% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.74%
EPS Next 5 Year
8.04%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.18%
Revenue Next 5 Year
5.57%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
14.47%
EBIT Next 5 Year
11.67%
NEURONES / NRO.PA Forecast FAQ
What is the next earnings date for NRO stock?
NEURONES (NRO.PA) will report earnings on 2026-05-06.
Can you provide the consensus rating for NEURONES stock?
The consensus rating for NEURONES (NRO.PA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.